Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
FGF-21 对感染者脂肪组织和肝脏代谢的影响
基本信息
- 批准号:10864068
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-10 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueAffectBloodBody fatBrown FatChronic DiseaseClinicalComplexCoupledDataDefectDevelopmentDiabetes MellitusDiseaseDissectionDyslipidemiasEndocrineEnergy MetabolismEsterificationExhibitsExpenditureFastingFatty LiverFatty acid glycerol estersFunctional disorderGene DeletionGene Expression RegulationGlucoseGoalsHIVHIV InfectionsHeart DiseasesHepaticHormonesImmunologyImpairmentIndirect CalorimetryInsulin ResistanceIntra-abdominalKineticsLinkLipidsLipolysisLiverLiver FailureMeasuresMetabolicMetabolic DiseasesMolecularMusPatientsPersonsPharmaceutical PreparationsPhysiologicalPhysiologyResearchSerumShapesSignal TransductionTestingThermogenesisTissuesViralVirusWorkabdominal fatantiretroviral therapycomorbidityenergy balancefatty acid oxidationfatty liver diseasefibroblast growth factor 21glucose metabolismimprovedinsulin sensitivityinsulin sensitizing drugsknockout genelifestyle interventionlipid metabolismliver metabolismmetabolic phenotypemouse modelnew therapeutic targetnovel therapeuticssubcutaneoustargeted treatmenttherapeutic targettransgene expressionvpr Gene Productswasting
项目摘要
ABSTRACT
HIV and antiretroviral therapy (ART) are associated with adipose tissue (AT) dysfunction and
systemic metabolic alterations, including intra-abdominal fat accumulation, fatty liver disease,
dyslipidemia, and insulin resistance. Treatment of these defects using conventional drugs and
lifestyle interventions has been minimally effective. Viral factors and ART contribute to the
complex pathophysiology of these disease states in persons living with HIV (PLWH). Still, the
mechanisms that link viral factors and ART to defective AT and hepatic metabolism remain
incompletely understood. We have demonstrated in mouse models that the HIV accessory
protein Vpr is sufficient to cause all the cardinal manifestations of HIV-associated metabolic
disease. The Vpr mice also have high levels of FGF21 and increased subcutaneous AT
thermogenesis. The current proposal aims to establish mechanistic connections between
increased FGF21 levels, white AT thermogenesis, and the observed metabolic abnormalities in
Vpr mice and PLWH. Our central hypothesis is that Vpr expression alters the metabolic effects
of FGF21, altering AT and hepatic function and inducing maladaptive browning of subcutaneous
white AT. We will test this hypothesis by achieving the following Specific Aims: 1) Determine
how Vpr exposure affects white AT thermogenesis in mice; 2) Demonstrate how FGF21 shapes
the metabolic abnormalities of Vpr mice; 3) Establish relationships between FGF21’s endocrine
actions and defects of lipid and glucose metabolism and subcutaneous white AT function in
PLWH on suppressive ART. Our research plan will provide detailed dissection of the
relationships between HIV-associated metabolic disease and FGF21 physiology, molecular
mechanisms of thermogenesis and AT physiology, and immunology. The project will reveal
mechanisms of unique metabolic defects in Vpr mouse models that recapitulate those in PLWH,
and elucidate how FGF21’s endocrine functions contribute to HIV-associated metabolic
abnormalities in PLWH on ART. Ultimately, this translational work will identify mechanisms of
HIV-specific metabolic alterations and may identify therapeutic targets that can be exploited to
minimize the long-term clinical burden of metabolic disease in PLWH.
抽象的
HIV和前视疗法(ART)与脂肪组织(AT)功能障碍和
全身代谢改变,包括腹腔内脂肪的积累,脂肪肝病,
血脂血症和胰岛素抵抗。
生活方式干预措施至少有效。
患有艾滋病毒的人(PLWH)的复杂病理生理学
将病毒因素和艺术与肝代谢有缺陷联系起来的机制仍然存在
我们在鼠标模型中证明了艾滋病毒附件
提供蛋白质VPR可引起与HIV相关代谢的所有基本表现
疾病。
当前的建议旨在建立机械连接
FGF21水平升高,热发生时白色以及观察到的代谢异常
VPR小鼠和PLWH。
FGF21,在肝功能上改变并诱发皮下不良适应性褐变
白色。
VPR暴露在小鼠中如何影响白色; 2)
VPR小鼠的代谢异常; 3)
脂质和葡萄糖代谢的作用和缺陷以及功能下的皮下白色
抑制艺术的PLWH。
HIV相关的代谢疾病与FGF21生理学,分子之间的关系
生理学和生理学的机制和免疫学会揭示
VPR小鼠模型中独特代谢缺陷的机制,这些机制概括了PLWH的机制,
并阐明FGF21的内分泌功能如何促进艾滋病毒的代谢
Art的PLWH异常,这个翻译工作世界。
HIV特异性的代谢替代性,并可能识别可以利用的治疗靶标
最大程度地减少PLWH代谢疾病的长期临床负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jordan E Lake其他文献
Jordan E Lake的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jordan E Lake', 18)}}的其他基金
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
FGF-21 对感染者脂肪组织和肝脏代谢的影响
- 批准号:
10434945 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
FGF-21 对感染者脂肪组织和肝脏代谢的影响
- 批准号:
10259862 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
FGF-21 对感染者脂肪组织和肝脏代谢的影响
- 批准号:
10654546 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Metabolic impact of FGF-21 in adipose tissue and liver of PLWH
FGF-21 对感染者脂肪组织和肝脏代谢的影响
- 批准号:
10054060 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
CBT and Exercise to Reduce Pain and Substance Use in Older Adults with HIV
CBT 和运动可减少感染艾滋病毒的老年人的疼痛和药物使用
- 批准号:
8770491 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Inflammation, Fibrosis and End-Organ Disease in HIV-Infected Adults
HIV 感染成人的炎症、纤维化和终末器官疾病
- 批准号:
8853808 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Inflammation, Fibrosis and End-Organ Disease in HIV-Infected Adults
HIV 感染成人的炎症、纤维化和终末器官疾病
- 批准号:
9284388 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
Inflammation, Fibrosis and End-Organ Disease in HIV-Infected Adults
HIV 感染成人的炎症、纤维化和终末器官疾病
- 批准号:
9379774 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
FTL+ALB+脂肪干细胞与CD36+EBF2-内皮细胞通过交互作用影响脂肪组织衰老的机制研究
- 批准号:82370884
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
白色脂肪组织HIF-1α/ATGL通路在心衰时对心肌细胞线粒体功能的影响及相关机制
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
层粘连蛋白调控巨噬细胞和脂肪基质细胞影响肥胖脂肪组织重塑的机制
- 批准号:
- 批准年份:2019
- 资助金额:300 万元
- 项目类别:
糖尿病肾病外泌体miRNAs介导内脏脂肪组织巨噬细胞-系膜细胞crosstalk影响肾脏自噬功能及丹酚酸B的作用
- 批准号:81974531
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
脂肪组织条件性Ubc9敲除对小鼠脂肪细胞及机体能量代谢影响的研究
- 批准号:81873656
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Role of SIK3 in PKA/mTORC1 regulation of adipose browning
SIK3 在 PKA/mTORC1 调节脂肪褐变中的作用
- 批准号:
10736962 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Lipid storage and utilization in physiology and obesity
生理学和肥胖中的脂质储存和利用
- 批准号:
10663760 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Regulation of beige adipocyte plasticity in inguinal white adipose tissue.
腹股沟白色脂肪组织中米色脂肪细胞可塑性的调节。
- 批准号:
10563617 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别: